Seedlings’ LifeCard patent found invalid and not infringed by Pfizer’s EpiPen

Published date06 February 2020
Subject MatterPatents,Expert Testimony,Obviousness,Claim Construction,Patent Litigation,Canada,Patent Infringement,Patent Invalidity,Anticipation,Pharmaceutical Industry
AuthorChen Li
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT